CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $1.853M (100.0% shares, 0.0% debt)

Holdings (10)

SPCX SPACE EXPLORATION TECHN CORP 24.0%

Value $445K Shares 2,606 Est. Cost — Unrealized —

BRK/B BERKSHIRE HATHAWAY INC DEL 20.3%

Value $377K Shares 754 Est. Cost — Unrealized —

GOOGL ALPHABET INC 13.3%

Value $247K Shares 691 Est. Cost — Unrealized —

VOO VANGUARD INDEX FDS 12.6%

Value $233K Shares 339 Est. Cost — Unrealized —

BX BLACKSTONE INC 10.2%

Value $188K Shares 1,597 Est. Cost — Unrealized —

KYTX KYVERNA THERAPEUTICS INC 5.9%

Value $110K Shares 12,347 Est. Cost — Unrealized —

LXEO LEXEO THERAPEUTICS INC 4.3%

Value $78,959 Shares 16,962 Est. Cost — Unrealized —

XFOR X4 PHARMACEUTICALS INC 3.9%

Value $72,650 Shares 15,557 Est. Cost — Unrealized —

IKT INHIBIKASE THERAPEUTICS INC 3.1%

Value $57,759 Shares 28,453 Est. Cost — Unrealized —

ALXO ALX ONCOLOGY HLDGS INC 2.3%

Value $43,358 Shares 20,946 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
SPCX	SPACE EXPLORATION TECHN CORP	2,606	$445K	24.0%	—	—	PUT	84615Q103
BRK/B	BERKSHIRE HATHAWAY INC DEL	754	$377K	20.3%	—	—	CL B NEW	084670702
GOOGL	ALPHABET INC	691	$247K	13.3%	—	—	CAP STK CL A	02079K305
VOO	VANGUARD INDEX FDS	339	$233K	12.6%	—	—	S&P 500 ETF SHS	922908363
BX	BLACKSTONE INC	1,597	$188K	10.2%	—	—	COM	09260D107
KYTX	KYVERNA THERAPEUTICS INC	12,347	$110K	5.9%	—	—	COM	501976104
LXEO	LEXEO THERAPEUTICS INC	16,962	$78,959	4.3%	—	—	COM	52886X107
XFOR	X4 PHARMACEUTICALS INC	15,557	$72,650	3.9%	—	—	COM NEW	98420X202
IKT	INHIBIKASE THERAPEUTICS INC	28,453	$57,759	3.1%	—	—	COM NEW	45719W205
ALXO	ALX ONCOLOGY HLDGS INC	20,946	$43,358	2.3%	—	—	COM	00166B105